Skip to main content
. 2023 Sep 16;17(20):19613–19624. doi: 10.1021/acsnano.3c01534

Figure 7.

Figure 7

miR-126+ ELVs increase vessel formation and vessel size 28 days after treatment. (A) Representative images of isolectin-B4+, SMA+, and MHC+ vessels in ischemic myocardium 28 days after vesicle injection. (B) Quantification of isolectin-B4+ vessel area and vessel size in myocardium. (C, D) Quantification of SMA+ and MHC+ vessel size in myocardium. SMA = smooth muscle actin. SM-MHC = smooth muscle-myosin heavy chain. Significance was tested with one-way ANOVA with Tukey posthoc. n.s. = not significant, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Scale bar = 100 μm.